初次孤立性主动脉瓣置换术中生物瓣膜的比较:一项全国性研究
该研究基于韩国国民健康保险服务数据库,纳入2003至2019年接受初次孤立性主动脉瓣置换术的成年患者,比较牛心包瓣膜与猪瓣膜的早期和长期临床结局。总体队列中猪瓣膜组全因死亡率累积发生率较高(调整后风险比1.20,P=0.002),但倾向性评分匹配后差异消失(P=0.24),两组晚期卒中、再手术和感染性心内膜炎发生率无显著差异。结论认为两种生物瓣膜的早期和长期临床结局无显著差异。
要点
- 匹配前猪瓣膜组全因死亡率较高(调整后风险比1.20,P=0.002)。
- 倾向性评分匹配后两组全因死亡率差异消失(P=0.24)。
- 两组早期死亡与并发症、晚期卒中、再手术及感染性心内膜炎无显著差异。
核心结论
- 在初次孤立性主动脉瓣置换术中,牛心包瓣膜与猪瓣膜的早期和长期临床结局无显著差异。
研究设计与样本
- 使用韩国国民健康保险服务理赔数据,纳入2003至2019年接受初次孤立性主动脉瓣置换术的成年患者(年龄≥19岁),并进行倾向性评分匹配分析。
- 总体纳入5470例患者,牛心包瓣膜组3947例,猪瓣膜组1523例;倾向性评分匹配后形成814对。
主要发现
- 总体队列中猪瓣膜组全因死亡率累积发生率高于牛心包瓣膜组(牛心包瓣膜组5.3%/患者年 vs 猪瓣膜组6.4%/患者年,调整后风险比1.20,P=0.002)。
- 倾向性评分匹配分析中全因死亡率差异消失(P=0.24)。
- 匹配人群中两组晚期卒中、再手术和感染性心内膜炎的累积发生率无显著差异。
- 匹配前后两组早期术后死亡率和并发症发生率相当。
临床怎么用
- 在初次孤立性主动脉瓣置换术选择生物瓣膜时,牛心包瓣膜与猪瓣膜的早期和长期临床结局相似,瓣膜选择可综合考虑其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to comprehensively compare the early and long-term clinical outcomes of bovine pericardial valve (BOV) and porcine valve (POV), specifically during the primary isolated aortic valve replacement (AVR), using data from the Korean National Health Insurance Service (NHIS) database. METHODS: Using the Korean NHIS claimed data, all adult patients (age ≥19) who underwent primary isolated AVR using bioprosthetic valve from 2003 to 2019 were identified and propensity-score matching (PSM) analysis was performed. RESULTS: Overall, 5470 patients with BOV (n = 3947, group B) or POV (n = 1,523, group P) were enrolled, of whom 814 pairs were matched in a 1:1 ratio using PSM analysis. Early postoperative mortality and morbidities were comparable between the groups before and after PSM, considering inter-hospital clustering. The cumulative incidence of all-cause mortality was higher in group P than in group B in the total cohort (group B 5.3%/patient-years vs group P 6.4%/patient-years, adjusted hazard ratio: 1.20, P = 0.002), whereas those differences in all-cause mortality disappeared in PSM analysis (P = 0.24). The cumulative incidences of late stroke, reoperation and infective endocarditis were not significantly different between the groups in PSM populations. CONCLUSIONS: In Korean national database cohort patients with primary isolated AVR, there was no significant difference in the early- and long-term clinical outcomes between BOV and POV.
引用
- Kim JS, Kim J, Kang Y, et al. Comparison of bioprosthetic valves in primary isolated aortic valve replacement: a nationwide study†. Eur J Cardiothorac Surg. 2025. PMID: 39932873. doi:10.1093/ejcts/ezaf031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。